Reimagining Diabetes: From Molecular Mechanisms to Transformative Therapies (A3)
February 1-4, 2027  | Keystone Resort, Keystone, CO, United States
Anna Krook, Jennifer Green and David Moller
Scholarship Deadline: Oct. 7, 2026 | Abstract Deadline: Jan. 12, 2027 | Early Registration Deadline: Dec. 3, 2026
* Session Chair † Invited but not yet accepted | Program current as of September 15, 2026 7 AM | For the most up-to-date details, visit https://www.keystonesymposia.org
Monday, February 1, 2027
1:00–6:00 PM Registration Longs Peak Foyer
3:00–3:10 PM Welcome Remarks Grays Peak
3:10–4:00 PM Keynote Address Grays Peak
  Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute
The Expanding Benefits of GLP-1 Medicines-is Weight Loss Always Critical
 
4:00–6:00 PM Fine Tuning our Understanding of Genetic Causes for Metabolic Disease Grays Peak
  Ruth J Loos, University of Copenhagen
Identification of Genes and Genetic Loci Contributing to the Risk of Obesity and Related Traits
 
  Melina Claussnitzer, Broad Institute, Harvard Medical School and Massachusetts General Hospital
Moving from Variant to Function to Tractable Therapeutic Hypotheses
 
  Bart O Roep, LUMC
Genetic beta-Cell Protection Modulating Type 1 Diabetes
 
  Short Talk(s) Chosen from Abstracts
 
6:00–8:00 PM Welcome Reception with Heavy Apps Longs Peak Foyer
Tuesday, February 2, 2027
7:00–8:00 AM Breakfast Longs Peak
8:00–11:00 AM Breakthrough Opportunities for Type 1 Diabetes and Preservation of Pancreatic B-Cell Mass-Function Grays Peak
  Matthias Hebrok, Technical University Munich and Helmholtz Center Munich
Advances toward Realizing the Goal of Stem Cell-Derived Islet Replacement Therapies
 
  Andrew F. Stewart, Mount Sinai School of Medicine
Novel Approaches for Pancreatic Beta Cell Regeneration
 
  Kevan C. Herold, Yale University
Clinical Trial Advances to Decode Beta Cell Resilience in Type 1 Diabetes: Cellular Pathways that Prevent Immune Destruction
 
  Lucy S. K. Walker, University College London
T Cell Dysregulation Type 1 Diabetes
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:10–12:10 PM Panel Discussion 1: What are Current Issues in Trial Design Diabetes-Obesity Clinical Trials Grays Peak
  * Manu Chakravarthy, Roche
 
12:10–1:00 PM Poster Setup Longs Peak
12:10–2:30 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Longs Peak
2:30–4:30 PM Symposia Spotlight 1: Basic Aspects of Diabetes Pathophysiology Grays Peak
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM New Mechanisms with Clinical Results Grays Peak
  David Moller, Third Rock Ventures
Overview of Emerging Clinical Trial Results - Impact and Implications
 
  David Kendall, Zealand Pharma
Amylin Biology-Rationale and Clinical Results
 
  Scott Harris, Altimmune Inc.
Harnessing Glucagon Agonism to Amplify Efficacy
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner Longs Peak
7:30–10:00 PM Poster Session 1 Longs Peak
Wednesday, February 3, 2027
7:00–8:00 AM Breakfast Longs Peak
8:00–11:00 AM Addressing Shortcomings and Expanding Use of Incretin-Based Therapies Grays Peak
  Philip Larsen, Sixpeaks Bio AG
Residual Challenges: Weight Regain, Sarcopenia, Long-Term Weight Maintenance
 
  Brian Finan, Eli Lilly
Incretin based Tri Agonists
 
  Lotte B Knudsen
GLP-1 and Beyond: Clinical Drug-Specific Mechanisms in Diabetes, Obesity, Cardiovascular, Kidney, Liver and Brain Diseases
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
9:20–9:25 PM Award Recipient Acknowledgement Grays Peak
11:10–12:10 PM Meet the Editors Grays Peak
12:10–1:00 PM Poster Setup Longs Peak
12:10–2:15 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Longs Peak
2:15–3:15 PM Career Roundtable Grays Peak
3:30–4:30 PM Panel: Health Equity Grays Peak
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM Disease Biology and Novel Therapeutic Targets Grays Peak
  Anna Krook, Karolinska Institutet
Skeletal Muscle as a Player in Pathobiology and a Therapeutic Target Organ
 
  Philipp E. Scherer, University of Texas Southwestern Medical Center
Novel Adipose Biology and Targets
 
  Judith A. Simcox, University of Wisconsin - Madison
Molecular and Cellular Regulation of Thermogenesis
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner Longs Peak
7:30–10:00 PM Poster Session 2 Longs Peak
Thursday, February 4, 2027
7:00–8:00 AM Breakfast Longs Peak
8:00–11:00 AM New Approaches Aimed at Modulating Energy Balance Grays Peak
  Randy J. Seeley, University of Michigan
Neural Pathways Regulating Food Intake and Energy Balance
 
  Katrin J. Svensson, Stanford University
Novel Peptides that Regulate Feeding and Obesity
 
  Eleftheria Maratos-Flier, Harvard Medical School and Alnylam
FGF21: What have we Learned from Mice and Human Trials?
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:00–2:30 PM On Own for Lunch
2:00–4:00 PM Symposia Spotlight 2: Novel Therapeutic Opportunities Grays Peak
  Short Talks Chosen from Abstracts
 
4:00–4:30 PM Coffee Available Longs Peak Foyer
4:30–6:15 PM Clinical Technology Innovations & Devices Grays Peak
  Jose C. Florez, Massachusetts General Hospital
Use of Big Data to Advance Precision Medicine in the Clinic
 
  Emmanuel Opara, Wake Forest Institute for Regenerative Medicine
Re-Engineering the Bioartificial Pancreas
 
  Aaron Kowalski, Juvenile Diabetes Research Foundation International
Technology Advances for Optimizing Care in Insulin-Requiring Patients
 
  Short Talk(s) Chosen from Abstracts
 
6:25–6:55 PM Panel Discussion 2: What Does the Future Hold for Strategies to Predict, Prevent, and Treat Diabetes Mellitus Grays Peak
  * Jennifer Green, Duke University
 
6:55–7:10 PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) Grays Peak
7:10–8:10 PM Social Hour with Dinner Longs Peak
8:00–9:00 PM Entertainment
8:10–9:00 PM Cash Bar
Friday, February 5, 2027
12:00–11:59 PM Departure